Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Pishposh Inc (BABY)

Pishposh Inc (BABY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Pishposh Inc 6701 KOLL CENTER PARKWAY SUITE 120 PLEASANTON CA 94566 USA

www.natus.com P: 925-223-6700

Description:

Natus Medical Incorporated is a leading provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments such as hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and newborn care. Product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, and software systems for managing and tracking disorders and diseases for public health laboratories.

Key Statistics

Overview:

Market Capitalization, $K 909,661
Shares Outstanding, K 34,006
Annual Sales, $ 530,890 K
Annual Net Income, $ -22,940 K
Last Quarter Sales, $ 114,760 K
Last Quarter Net Income, $ -30,000 K
60-Month Beta 0.57
% of Insider Shareholders 1.65%
% of Institutional Shareholders 91.56%
Float, K 33,445
% Float 98.35%

Growth:

1-Year Return -20.97%
3-Year Return -31.99%
5-Year Return -3.53%
5-Year Revenue Growth 54.28%
5-Year Earnings Growth 37.86%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.34 on 07/25/19
Next Earnings Date N/A
Earnings Per Share ttm 1.27
EPS Growth vs. Prev Qtr 277.78%
EPS Growth vs. Prev Year -2.86%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

BABY Ratios

Ratio
Price/Earnings ttm 21.59
Price/Earnings forward 21.06
Price/Earnings to Growth N/A
Return-on-Equity % 10.75%
Return-on-Assets % 6.56%
Profit Margin % -4.32%
Debt/Equity 0.17
Price/Sales 1.76
Price/Cash Flow 9.39
Price/Book 2.47
Book Value/Share 10.83
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar